List view / Grid view
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Blocking a molecule could bypass bowel cancer’s defence against the drug cetuximab, according to new research presented at the National Cancer Research...
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
BenevolentAI, a British artificial intelligence company has signed an exclusive license for a series of novel clinical stage drug candidates with Janssen...
9 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In this newly-created role, Dr Antonijevic will be responsible for advancing the clinical development of vasopharm’s lead ongoing program, VAS203...
8 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The EU and the Swiss government gave €6.3 million for the Next-Lab project, which aims to bring changes in the way that science, engineering and technology are taught in Europe...
8 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Oxytocin, which is produced in the hypothalamus in the brain, has a number of important functions in the body of mammals...
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers have found an anti-inflammatory drug that blocks certain inflammation pathways prevented pre-term birth entirely in pregnant mice...
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Patients with malignant melanoma are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria, according to...
7 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The fibre optics research at KTH covers everything from bio-implants via medical sensors to solar cells and the researchers aim to have developed several...
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Researchers used pioneering techniques to develop a `small molecule’ chemical probe which offers highly targeted access to the hypoxic signalling pathway...
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
The agreed long-term collaboration will take strengths from both companies to collaborate on the HPV vaccine although financial details of this agreement...
4 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Øystein Soug is the former CFO of Algeta, a Norwegian oncology biotech company which was sold to Bayer for USD 2.9 billion in 2014...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
Bicyclic nitro-drugs used in the treatment of tuberculosis, including the recently approved drug delamanid, were reported as promising fast track options...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
JangoBio announces their founding as a company focused on developing new therapies to sustainably reverse hormone imbalances associated with ageing...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A new study csuggests that Ebola virus gained a genetic mutation during the 2013 – 16 epidemic that appears to have helped it better target human cells...
3 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A recent investment of €3.3 million will allow researchers to improve the detail of medical imaging ten times over, which will allow for tumour scanning...
